Tolerance Induction to Cytoplasmic β-Galactosidase by Hepatic AAV Gene Transfer — Implications for Antigen Presentation and Immunotoxicity
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Hepatic gene transfer, in particular using adeno-associated viral (AAV) vectors, has been shown to induce immune tolerance to several protein antigens. This approach has been exploited in animal models of inherited protein deficiency for systemic delivery of therapeutic proteins. Adequate levels of transgene expression in hepatocytes induce a suppressive T cell response, thereby promoting immune tolerance. This study addresses the question of whether AAV gene transfer can induce tolerance to a cytoplasmic protein. MAJOR FINDINGS: AAV-2 vector-mediated hepatic gene transfer for expression of cytoplasmic beta-galactosidase (beta-gal) was performed in immune competent mice, followed by a secondary beta-gal gene transfer with E1/E3-deleted adenoviral Ad-LacZ vector to provoke a severe immunotoxic response. Transgene expression from the AAV-2 vector in approximately 2% of hepatocytes almost completely protected from inflammatory T cell responses against beta-gal, eliminated antibody formation, and significantly reduced adenovirus-induced hepatotoxicity. Consequently, approximately 10% of hepatocytes continued to express beta-gal 45 days after secondary Ad-LacZ gene transfer, a time point when control mice had lost all Ad-LacZ derived expression. Suppression of inflammatory T cell infiltration in the liver and liver damage was linked to specific transgene expression and was not seen for secondary gene transfer with Ad-GFP. A combination of adoptive transfer studies and flow cytometric analyses demonstrated induction of Treg that actively suppressed CD8(+) T cell responses to beta-gal and that was amplified in liver and spleen upon secondary Ad-LacZ gene transfer. CONCLUSIONS: These data demonstrate that tolerance induction by hepatic AAV gene transfer does not require systemic delivery of the transgene product and that expression of a cytoplasmic neo-antigen in few hepatocytes can induce Treg and provide long-term suppression of inflammatory responses and immunotoxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“mouse studies have shown liver-directed AAV gene therapy results in tolerogenic responses by the induction of Tregs,52, 53, 54, 55, 56, 57, 58, 59”
From Modulating immune responses to AAV by expanded polyclonal T-regs and capsid specific chimeric antigen receptor T-regulatory cells (2021) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease
Sakaguchi, S., Ono, M., Setoguchi, R., Yagi, H., Hori, S., Fehervari, Z., Shimizu, J., Takahashi, T., & Nomura, T. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00427.x · Cited by 1,555
Hauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954 · cited 1×
“treatment of patients with Leber’s Congenital Amaurosis, a rare form of inherited blindness, correction of sarcoglycan deficiency in skeletal muscle of dystrophic patients, and multi-year correction of hemophilia in canine models by a single hepatic administration [12,13].”
BackgroundSelf-citationThe inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response
Muruve, D. A., Pétrilli, V., Zaiss, A. K., White, L. R., Clark, S. A., Ross, P. J., Parks, R. J., & Tschopp, J. (2008) · Nature · doi:10.1038/nature06664 · Cited by 936
Xiao, X., Li, J., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8098-8108.1996 · Cited by 912
Recombinant adeno-associated virus for muscle directed gene therapy
Fisher, K. J., Jooss, K., Alston, J., Yang, Y., Haecker, S. E., High, K., Pathak, R., Raper, S. E., & Wilson, J. M. (1997) · Nature Medicine · doi:10.1038/nm0397-306 · Cited by 654 · cited 1×
“an adeno-associated viral (AAV) vector instead of adenovirus [5–8].”
BackgroundKessler, P. D., Podsakoff, G. M., Chen, X., McQuiston, S. A., Colosi, P. C., Matelis, L. A., Kurtzman, G. J., & Byrne, B. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14082 · Cited by 614
Self-citationSawa, A., Wiegand, G. W., Cooper, J., Margolis, R. L., Sharp, A. H., Lawler, J. F., Greenamyre, J. T., Snyder, S. H., & Ross, C. A. (1999) · Nature Medicine · doi:10.1038/13518 · Cited by 552
Brown, B. D., Venneri, M. A., Zingale, A., Sergi, L. S., & Naldini, L. (2006) · Nature Medicine · doi:10.1038/nm1398 · Cited by 484
Herzog, R. W., Hagstrom, J. N., Kung, S.-H., Tai, S. J., Wilson, J. M., Fisher, K. J., & High, K. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5804 · Cited by 474
Self-citationJooss, K., Yang, Y., Fisher, K. J., & Wilson, J. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.4212-4223.1998 · Cited by 470 · cited 2×
“This is in contrast to findings by others on muscle gene transfer, showing that secondary Ad-LacZ gene transfer eliminates previously AAV-LacZ transduced skeletal muscle fibers [4].”
BackgroundResultInduction of Immune Tolerance to Coagulation Factor IX Antigen by In Vivo Hepatic Gene Transfer
Mingozzi, F., Liu, Y.-L., Dobrzynski, E., Kaufhold, A., Liu, J. H., Wang, Y., Arruda, V. R., High, K. A., & Herzog, R. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16887 · Cited by 466 · cited 3×
“from an effector to a regulatory response [18,25].”
BackgroundMethodSelf-citationAdenovirus–mediated in vivo gene transfer and expression in normal rat liver
Jaffe, H. A., Danel, C., Longenecker, G., Metzger, M., Setoguchi, Y., Rosenfeld, M. A., Gant, T. W., Thorgeirsson, S. S., Stratford-Perricaudet, L. D., Perricaudet, M., et al. (1992) · Nature Genetics · doi:10.1038/ng0892-372 · Cited by 449
Snyder, R. O., Miao, C., Meuse, L., Tubb, J., Donahue, B. A., Lin, H.-F., Stafford, D. W., Patel, S., Thompson, A. R., Nichols, T., et al. (1999) · Nature Medicine · doi:10.1038/4751 · Cited by 409
The Innate Immune Response to Adenovirus Vectors
Muruve, D. A. (2004) · Human Gene Therapy · doi:10.1089/hum.2004.15.1157 · Cited by 407
Yang, Y., Jooss, K. U., Su, Q., Ertl, H. C. J., & Wilson, J. M. (1996) · PubMed · Cited by 375
Assessment of Recombinant Adenoviral Vectors for Hepatic Gene Therapy
Li, Q., Kay, M. A., Finegold, M., Stratford-Perricaudet, L. D., & Woo, S. L. C. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.4-403 · Cited by 305
Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo
Yang, Y., & Wilson, J. M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2564 · Cited by 262
Yang, Y., Xiang, Z., Ertl, H. C., & Wilson, J. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7257 · Cited by 260
Mingozzi, F., Hasbrouck, N. C., Basner-Tschakarjan, E., Edmonson, S. A., Hui, D. J., Sabatino, D. E., Zhou, S., Wright, J. F., Jiang, H., Pierce, G. F., et al. (2007) · Blood · doi:10.1182/blood-2007-03-080093 · Cited by 254 · cited 1×
“Hepatocyte-derived antigen can induce a regulatory response, mediated by Treg, that actively suppresses humoral and cellular immune responses [21–23].”
BackgroundRegulatory T Cells Dynamically Control the Primary Immune Response to Foreign Antigen
Haribhai, D., Lin, W., Relland, L. M., Truong, N., Williams, C. B., & Chatila, T. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2961 · Cited by 244
Cellular and molecular mechanisms of liver tolerance
Crispe, I. N., Giannandrea, M., Klein, I., John, B., Sampson, B., & Wuensch, S. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00435.x · Cited by 234
Cao, O., Dobrzynski, E., Wang, L., Nayak, S., Mingle, B., Terhorst, C., & Herzog, R. W. (2007) · Blood · doi:10.1182/blood-2007-02-073304 · Cited by 220
Self-citationSnyder, R. O., Spratt, S. K., Lagarde, C., Bohl, D., Kaspar, B., Sloan, B., Cohen, L. K., & Danos, O. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.16-1891 · Cited by 211
Jiang, H., Pierce, G. F., Ozelo, M. C., de Paula, E. V., Vargas, J. A., Smith, P., Sommer, J., Luk, A., Manno, C. S., High, K. A., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.004 · Cited by 207
Lüth, S., Huber, S., Schramm, C., Buch, T., Zander, S., Stadelmann, C., Brück, W., Wraith, D. C., Herkel, J., & Lohse, A. W. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32132 · Cited by 161
Arruda, V. R., Stedman, H. H., Nichols, T. C., Haskins, M. E., Nicholson, M., Herzog, R. W., Couto, L. B., & High, K. A. (2005) · Blood · doi:10.1182/blood-2004-07-2908 · Cited by 153
Self-citationImmunology of gene therapy with adenoviral vectors in mouse skeletal muscle
Yang, Y. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.11.1703 · Cited by 152
Role of primary intrahepatic T‐cell activation in the ‘liver tolerance effect’
Bertolino, P., McCaughan, G. W., & Bowen, D. G. (2002) · Immunology & Cell Biology · doi:10.1046/j.0818-9641.2001.01048.x · Cited by 147
Induction of antigen-specific CD4+ T-cell anergy and deletion by in vivo viral gene transfer
Dobrzynski, E., Mingozzi, F., Liu, Y.-L., Bendo, E., Cao, O., Wang, L., & Herzog, R. W. (2004) · Blood · doi:10.1182/blood-2004-03-0847 · Cited by 135
Self-citationSun, B., Bird, A., Young, S. P., Kishnani, P. S., Chen, Y.-T., & Koeberl, D. D. (2007) · The American Journal of Human Genetics · doi:10.1086/522236 · Cited by 130
Fields, P. A., Kowalczyk, D. W., Arruda, V. R., Armstrong, E., McCleland, M. L., Hagstrom, J. N., Pasi, K. J., Ertl, H. C. J., Herzog, R. W., & High, K. A. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0032 · Cited by 129
Self-citationWalter, J., You, Q., Hagstrom, J. N., Sands, M., & High, K. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.3056 · Cited by 120
Yuasa, K., Yoshimura, M., Urasawa, N., Ohshima, S., Howell, J. M., Nakamura, A., Hijikata, T., Miyagoe‐Suzuki, Y., & Takeda, S. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302984 · Cited by 117
Hepatic Gene Transfer as a Means of Tolerance Induction to Transgene Products
LoDuca, P., Hoffman, B., & Herzog, R. (2009) · Current Gene Therapy · doi:10.2174/156652309787909490 · Cited by 114
Self-citationXiao, W., Chirmule, N., Schnell, M. A., Tazelaar, J., Hughes, J. V., & Wilson, J. M. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0045 · Cited by 114
Dobrzynski, E., Fitzgerald, J. C., Cao, O., Mingozzi, F., Wang, L., & Herzog, R. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508685103 · Cited by 105
Self-citationMajor role of local immune responses in antibody formation to factor IX in AAV gene transfer
Wang, L., Cao, O., Swalm, B., Dobrzynski, E., Mingozzi, F., & Herzog, R. W. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302539 · Cited by 98
Self-citationImproved Induction of Immune Tolerance to Factor IX by Hepatic AAV-8 Gene Transfer
Cooper, M., Nayak, S., Hoffman, B. E., Terhorst, C., Cao, O., & Herzog, R. W. (2009) · Human Gene Therapy · doi:10.1089/hum.2008.161 · Cited by 90
Self-citationOptimized Production of High-Titer Recombinant Adeno-Associated Virus in Roller Bottles
Liu, Y.-L., Wagner, K., Robinson, N., Sabatino, D., Margaritis, P., Xiao, W., & Herzog, R. W. (2003) · BioTechniques · doi:10.2144/03341dd07 · Cited by 67
Self-citationPassini, M. A., Bu, J., Fidler, J. A., Ziegler, R. J., Foley, J. W., Dodge, J. C., Yang, W. W., Clarke, J., Taksir, T. V., Griffiths, D. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703509104 · Cited by 67
De Geest, B. R., Van Linthout, S. A., & Collen, D. (2003) · Blood · doi:10.1182/blood-2002-07-2146 · Cited by 63
Sarukhan, A., Soudais, C., Danos, O., & Jooss, K. (2001) · The Journal of Gene Medicine · doi:10.1002/jgm.175 · Cited by 60
Cresawn, K. O., Fraites, T. J., Wasserfall, C., Atkinson, M., Lewis, M., Porvasnik, S., Liu, C., Mah, C., & Byrne, B. J. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.68 · Cited by 57
Self-citationOverwijk, W. W., Surman, D. R., Tsung, K., & Restifo, N. P. (1997) · Methods · doi:10.1006/meth.1997.0461 · Cited by 54
Tolerance Induction by Viral In Vivo Gene Transfer
Dobrzynski, E., & Herzog, R. W. (2005) · Clinical Medicine & Research · doi:10.3121/cmr.3.4.234 · Cited by 47
Self-citationImmune Responses to Gene Product of Inducible Promoters
Guiner, C., Stieger, K., Snyder, R., Rolling, F., & Moullier, P. (2007) · Current Gene Therapy · doi:10.2174/156652307782151461 · Cited by 46
Muscle as a Target for Supplementary Factor IX Gene Transfer
Hoffman, B. E., Dobrzynski, E., Wang, L., Hirao, L., Mingozzi, F., Cao, O., & Herzog, R. W. (2007) · Human Gene Therapy · doi:10.1089/hum.2007.042 · Cited by 44
Self-citationEmerging Role of Regulatory T Cells in Gene Transfer
Cao, O., Furlan-Freguia, C., Arruda, V., & Herzog, R. (2007) · Current Gene Therapy · doi:10.2174/156652307782151506 · Cited by 26
Self-citation
Cited by
Immune responses to AAV vectors: overcoming barriers to successful gene therapy
Mingozzi, F., & High, K. A. (2013) · Blood · doi:10.1182/blood-2013-01-306647 · Cited by 955
Emerging issues in AAV-mediated in vivo gene therapy
Colella, P., Ronzitti, G., & Mingozzi, F. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2017.11.007 · Cited by 881
Progress and prospects: immune responses to viral vectors
Nayak, S., & Herzog, R. W. (2010) · Gene Therapy · doi:10.1038/gt.2009.148 · Cited by 634
Self-citationAAV-Mediated Gene Therapy for Research and Therapeutic Purposes
Samulski, R. J., & Muzyczka, N. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085355 · Cited by 551
How Tolerogenic Dendritic Cells Induce Regulatory T Cells
Maldonado, R. A., & von Andrian, U. H. (2010) · Advances in Immunology · doi:10.1016/b978-0-12-380995-7.00004-5 · Cited by 541
Metadata
- Authors
- Martino, A. T., Nayak, S., Hoffman, B. E., Cooper, M., Liao, G., Markusic, D. M., Byrne, B. J., Terhorst, C., & Herzog, R. W.
- Affiliations
- University of Florida Health (US)
- University of Florida (US)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Herzog, Roland W.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-08-04
- Volume
- 4
- Issue
- 8
- Pages
- e6376
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2715858
- OpenAlex
- W2120423141
- Cited by
- 54
- References
- 48
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 1 · 2017: 6 · 2016: 4 · 2015: 1 · 2014: 8 · 2013: 6 · 2012: 2
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- American Heart Association
- University of Florida
- National Institutes of Health
- National Heart, Lung, and Blood Institute (P01HL078810)
- National Institute of Allergy and Infectious Diseases (R01AI051390, AI/HL51390)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK074367)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- immune tolerance induction, adeno-associated virus vectors, hepatic gene transfer, antigen presentation, immunotoxicity, regulatory T cells, CD8+ T cell suppression, adoptive transfer, liver inflammation
- MeSH terms
- Dependovirus, Animals, beta-Galactosidase, Cytoplasm, Genetic Vectors, Immune Tolerance, Liver, Mice, Inbred BALB C, Mice, Inbred C57BL, Transduction, Genetic, Gene Transfer Techniques, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.